UNSPSC 85893521: High dose rate (hdr) brachytherapy of pelvic region using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of pelvic region using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DW169BZ

UNSPSC 85893521 High dose rate (HDR) brachytherapy of pelvic region using palladium 103 (Pd-103) is a Commodity code that shows little relevant recent state and local procurement activity. The single recent opportunity identified under this code—County of Santa Clara Health System's solicitation RFSQHHSFY270052 for temporary health professional staffing services—bears no relationship to the code's nominal scope of specialized radiation oncology treatment. The Health System is establishing a qualified vendor pool for ancillary clinical staffing across thirteen categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic, respiratory care, sterile processing, surgical and operating room, and therapy services. The procurement explicitly excludes nursing, physician, and non-clinical staffing and operates as a non-exclusive, multiple-award qualification vehicle with no guaranteed work volume; the Health System may maintain the Qualified List for five years and contract with selected vendors as operational needs arise.

The mismatch between the code's medical physics scope and the actual staffing services being solicited suggests this code does not represent active state and local procurement for HDR brachytherapy treatment delivery. County of Santa Clara Health System posted the staffing RFQ on July 7, 2026, with proposals due October 7, 2026, accepting all submissions electronically. Without additional recent opportunities tied to the actual treatment modality named in the code, this UNSPSC category appears unsuitable as a procurement signal for business development focused on HDR brachytherapy services to state and local health systems.